We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.06B
AUM Growth
+$107M
Cap. Flow
-$28.6M
Cap. Flow %
-1.39%
Top 10 Hldgs %
29.47%
Holding
2,720
New
413
Increased
568
Reduced
616
Closed
259

Sector Composition

Rank Sector Weight
1 Technology 24.3%
2 Healthcare 11.82%
3 Financials 10.45%
4 Consumer Discretionary 9.39%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPK icon
1976
National Presto Industries
NPK
$987M
$18.4K ﹤0.01%
251
TRDA icon
1977
Entrada Therapeutics
TRDA
$290M
$18.4K ﹤0.01%
+1,212
New +$16.7K
VMD icon
1978
Viemed Healthcare
VMD
$349M
$18.3K ﹤0.01%
+1,876
New +$19.1K
CZFS icon
1979
Citizens Financial Services
CZFS
$393M
$18.2K ﹤0.01%
+250
New +$20.3K
PINE
1980
Alpine Income Property Trust
PINE
$347M
$18.2K ﹤0.01%
1,122
+724
+182% +$11.5K
OMER icon
1981
Omeros
OMER
$1.26B
$18.2K ﹤0.01%
+3,344
New +$19.5K
NRDS icon
1982
NerdWallet
NRDS
$639M
$18.2K ﹤0.01%
1,933
+389
+25% +$4.39K
CVLG icon
1983
Covenant Logistics
CVLG
$880M
$18.2K ﹤0.01%
830
-322
-28% -$6.22K
SCLX icon
1984
Scilex Holding
SCLX
$47.4M
$18.2K ﹤0.01%
93
CABA icon
1985
Cabaletta Bio
CABA
$442M
$18.2K ﹤0.01%
+1,406
New +$15.3K
BWMN icon
1986
Bowman Consulting
BWMN
$731M
$18.1K ﹤0.01%
+568
New +$16.6K
ITOS
1987
DELISTED
iTeos Therapeutics
ITOS
$18.1K ﹤0.01%
1,365
LYTS icon
1988
LSI Industries
LYTS
$912M
$18K ﹤0.01%
+1,436
New +$18K
BFLY icon
1989
Butterfly Network
BFLY
$2.36B
$18K ﹤0.01%
7,818
+3,200
+69% +$7.15K
MCB icon
1990
Metropolitan Bank Holding Corp
MCB
$1.17B
$18K ﹤0.01%
517
AXGN icon
1991
Axogen
AXGN
$2.58B
$17.9K ﹤0.01%
1,966
ALPN
1992
DELISTED
Alpine Immune Sciences Inc
ALPN
$17.9K ﹤0.01%
1,743
+1,206
+225% +$10.9K
PSFE icon
1993
Paysafe
PSFE
$405M
$17.9K ﹤0.01%
+1,774
New +$22.5K
TDAY
1994
USA Today Co
TDAY
$1B
$17.9K ﹤0.01%
7,939
AMRX icon
1995
Amneal Pharmaceuticals
AMRX
$6.02B
$17.8K ﹤0.01%
5,737
LPSN icon
1996
LivePerson
LPSN
$35.9M
$17.7K ﹤0.01%
262
+144
+122% +$9.34K
PNTG icon
1997
Pennant Group
PNTG
$1.35B
$17.7K ﹤0.01%
1,443
AMAL icon
1998
Amalgamated Financial
AMAL
$1.53B
$17.7K ﹤0.01%
1,098
INSE icon
1999
Inspired Entertainment
INSE
$164M
$17.6K ﹤0.01%
1,199
SFIX
2000
Stitch Fix
SFIX
$487M
$17.6K ﹤0.01%
4,580

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 Portfolio in Review

As of Q2 2023, Metropolitan Life Insurance Company (MetLife) held 2,720 positions worth $2.06B, up 5.5% from $1.95B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2023 filing shows 413 new, 568 increased, 616 reduced and 259 closed positions. Its largest new stake was Alphabet (Google) Class C: 222,708 shares worth $26.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2023 buy was Alphabet (Google) Class C: 222,708 shares worth $26.9M.
  • Metropolitan Life Insurance Company (MetLife) added most to Vanguard Total Bond Market in Q2 2023, an estimated $15M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $16.1M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Iridium Communications in Q2 2023, selling an estimated $418K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 29% of its $2.06B portfolio in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife) opened 413 new positions and closed 259 in Q2 2023.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 5.5% quarter-over-quarter to $2.06B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.